Literature DB >> 28448204

Future Research Opportunities in Peri-Prosthetic Joint Infection Prevention.

Elie Berbari1, John Segreti2, Javad Parvizi3, Sandra I Berríos-Torres4.   

Abstract

Peri-prosthetic joint infection (PJI) is a serious complication of prosthetic joint arthroplasty. A better understanding and reversal of modifiable risk factors may lead to a reduction in the incidence of incisional (superficial and deep) and organ/space (e.g., PJI) surgical site infections (SSI). Recently, the Centers for Disease Control and Prevention (CDC) and the Healthcare Infection Control Practices Advisory Committee (HICPAC) published the Guideline for Prevention of Surgical Site Infection. This targeted update applies evidence-based methodology in drafting recommendations for potential strategies to reduce the risk of SSI both across surgical procedures and specifically in prosthetic joint arthroplasty. A panel of PJI content experts identified nine PJI prevention research opportunities based on both evidence gaps identified through the guideline development process (transfusion, immunosuppressive therapy, anticoagulation, orthopedic space suit, and biofilm) and expert opinion (anesthesia, operative room environment, glycemic control, and Staphylococcus aureus nasal screening and decolonization. This article offers a road map for PJI prevention research.

Entities:  

Keywords:  prevention; prosthesis; surgical site infection

Mesh:

Year:  2017        PMID: 28448204     DOI: 10.1089/sur.2017.065

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  2 in total

1.  A Clinical Test to Measure Airborne Microbial Contamination on the Sterile Field During Total Joint Replacement: Method, Reference Values, and Pilot Study.

Authors:  John H Harp
Journal:  JB JS Open Access       Date:  2018-08-24

2.  General anesthesia might be associated with early periprosthetic joint infection: an observational study of 3,909 arthroplasties.

Authors:  Ruben Scholten; Borg Leijtens; Gerjon Hannink; Ed T Kamphuis; Matthijs P Somford; Job L C van Susante
Journal:  Acta Orthop       Date:  2019-07-24       Impact factor: 3.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.